‘Magic Mushroom’ Drug Shows Promise in Treating Addictions and Cancer Anxiety. Suspended for decades after controversial results, research on the hallucinogen psilocybin is showing early promise in a new series of small studies. In research presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP), scientists highlighted the latest findings on the use of psilocybin, the synthetic version of the active compound in “magic mushrooms,” as a treatment for anxiety in terminal cancer patients, in smoking cessation and as a treatment for alcoholism.
Some of the studies are not complete and have not yet been reviewed by other experts, but they provide new information on psilocybin’s effects. Psilocybin is the active ingredient in over 100 species of mushrooms in the Psilocybe class, used for hundreds of years in shamanic ceremonies and other rituals in South America.
(MORE: ‘Magic Mushrooms’ Trigger Lasting Personality Change) “[So] much of modern neurobiological chemistry results from studying psychedelics,” said Dr.
Post Traumatic Stress. Other Mental Stuff. LSD and other psychedelics not linked with mental health problems. Public release date: 19-Aug-2013 [ Print | E-mail Share ] [ Close Window ] Contact: Teri Krebskrebs@ntnu.no 47-922-93108Norwegian University of Science and Technology The use of LSD, magic mushrooms, or peyote does not increase a person's risk of developing mental health problems, according to an analysis of information from more than 130,000 randomly chosen people, including 22,000 people who had used psychedelics at least once.
Researcher Teri Krebs and clinical psychologist Pål-Ørjan Johansen, from the Norwegian University of Science and Technology's (NTNU) Department of Neuroscience, used data from a US national health survey to see what association there was, if any, between psychedelic drug use and mental health problems. The authors found no link between the use of psychedelic drugs and a range of mental health problems. Instead they found some significant associations between the use of psychedelic drugs and fewer mental health problems. Could psychedelics be healthy for you? 1st LSD study in 40 years. Update 5 March 2014: The study has been published, and the final copy is available here. LSD capsule from the Swiss study Rick Doblin, the founder and president of MAPS, said this in a recent “Ask Me Anything” interview on Reddit: We’ve just completed the world’s first study of the therapeutic use of LSD in over 40 years, in Switzerland to treat anxiety associated with end-of-life issues.
Eleven of the 12 subjects had never done LSD before and there were no serious adverse events, even in people facing death. Dr. Peter Gasser, who led the study This recently completed Swiss study is truly momentous — it’s the first “double-blind, placebo-controlled investigation of LSD-assisted psychotherapy since the early 1970s.” The paper, which was accepted for publication in the peer-reviewed Journal of Nervous and Mental Disease, makes these conclusions: Twelve is a very small sample size, but this study is not intended to be conclusive. A similar study, published in 2010 by Dr. Second, check out Dr.